Larvol Delta - BioThera-and-Richter-Execute-Exclusive-Commercialization-Agreement-for-BAT2206-a-Proposed-Stelara-Biosimilar-for-EU-countries-UK-Switzerland-and-other-selected-countries

BAT2206 (ustekinumab biosimilar) - Bio-Thera Solutions, Pharmapark, Hikma, Biomm, Gedeon Richter

https://www.prnewswire.com/news-releases/bio-thera-and-richter-execute-exclusive-commercialization-agreement-for-bat2206-a-proposed-stelara-biosimilar-for-eu-countries-uk-switzerland-and-other-selected-countries-302271432.html

Oct 9, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next